iodine has been researched along with Hand-Foot Syndrome in 2 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Hand-Foot Syndrome: Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lankheet, NA | 2 |
Huitema, AD | 2 |
Mallo, H | 2 |
Adriaansz, S | 2 |
Haanen, JB | 1 |
Schellens, JH | 2 |
Beijnen, JH | 2 |
Blank, CU | 2 |
Rosing, H | 1 |
1 trial available for iodine and Hand-Foot Syndrome
Article | Year |
---|---|
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome.
Topics: Aged; Antineoplastic Agents; Female; Hand-Foot Syndrome; Humans; Indoles; Male; Middle Aged; Pyrrole | 2013 |
1 other study available for iodine and Hand-Foot Syndrome
Article | Year |
---|---|
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Biotransformation; Calibration; Carcinoma, Renal | 2011 |